The full Weil legal team details were not immediately available.
With this deal, Halozyme isn’t just buying a company—it’s buying the future of injectable medicine, one concentrated dose at a time.
- America
- And More
- Business
- California News
- International
- Investigates
- New York News
- The People's Voice
- U.S. News
- USA Herald
